Anticoagulation Reversal

Introduction to Protamine Sulfate Administration

Protamine sulfate is recommended by the American College of Critical Care Medicine, the American Society of Anesthesiologists, and the American Heart Association for unfractionated heparin (UFH) reversal, with a dose of 1 mg for every 100 units of heparin given in the previous 2-3 hours, and a maximum single dose of 50 mg 1, 2, 3
The dose of protamine sulfate should be calculated based on the timing of the last heparin administration, considering heparin's half-life of approximately 30 minutes 1, 3

For administration within 2-3 hours after heparin, 1 mg protamine per 100 units of heparin is recommended 3, 4
For administration 30-60 minutes after heparin, 0.5-0.75 mg of protamine per 100 units of heparin is recommended 4
For administration 60-120 minutes after heparin, 0.375-0.5 mg of protamine per 100 units of heparin is recommended 4
For administration more than 120 minutes after heparin, 0.25-0.375 mg of protamine per 100 units of heparin is recommended 4
For low molecular weight heparin (LMWH) reversal:

Protamine sulfate should be administered by slow intravenous injection over 10 minutes, with a maximum infusion rate of 5 mg/min, as recommended by the American Society of Anesthesiologists and the American Heart Association 1, 2, 3, 4
Coagulation parameters such as activated partial thromboplastin time (aPTT) or activated clotting time (ACT) should be checked 5-10 minutes after protamine administration to monitor effectiveness 1, 2, 3
If aPTT remains elevated after initial protamine administration, additional protamine can be administered at 0.5 mg per 100 units of unfractionated heparin 3

Protamine is ineffective for reversing the effects of pentasaccharides, such as fondaparinux, and should not be used; instead, consider activated prothrombin complex concentrate (PCC) (20 IU/kg) or recombinant factor VIIa (90 μg/kg) if necessary 3
Routine reversal of prophylactic subcutaneous heparin is not necessary unless aPTT is significantly prolonged or if there is active bleeding, as recommended by the Society of Critical Care Medicine and the American College of Chest Physicians 3
Urgent reversal is recommended when intracranial hemorrhage develops during full-dose heparin infusion, following standard protamine dosing protocol, as recommended by the Society of Critical Care Medicine 3

Protamine only partially reverses low molecular weight heparin (LMWH), with approximately 60-75% of anti-Xa activity neutralized, as noted by the American College of Critical Care Medicine 1, 3, 5
No well-established alternatives exist for UFH reversal, and recombinant factor VIIa has been suggested in some cases, but evidence is limited and it's not FDA-approved for this indication 3

Hypotension, bradycardia, and anaphylactoid reactions can occur with protamine administration, especially with rapid administration, and it should be given only when resuscitation techniques and treatment for anaphylactoid shock are readily available 1
Excess protamine can induce a coagulopathy by inhibiting factor V activation and reducing thrombin generation, and should be avoided 1